Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Mesenchymal stromal cells (MSC) are tested in clinical trials to treat graft versus host disease (GvHD) after stem cell transplantation (SCT). In vitro studies demonstrated MSC's broad immunosuppressive activity. As infections represent a major risk after SCT, it is important to understand the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lucchini, Giovanna, Dander, Erica, Pavan, Fabio, Di Ceglie, Irene, Balduzzi, Adriana, Perseghin, Paolo, Gaipa, Giuseppe, Algarotti, Alessandra, Introna, Martino, Rambaldi, Alessandro, Rovelli, Attilio, Biondi, Andrea, Biagi, Ettore, D'Amico, Giovanna
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2012
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369546/
https://ncbi.nlm.nih.gov/pubmed/22701127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/690236
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge